Advanced Filters
noise

A, Kuopio N Clinical Trials

A listing of A, Kuopio N clinical trials actively recruiting patients volunteers.

Found 11,558 clinical trials

A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults who have recently quit. Study participation will last approximately 34 weeks with up to 17 study visits, which includes a 2-week screening period, 24-week treatment period, …

18 - 75 years of age All Phase 2
M Muhammad Asif Javed, MS

Agility and Sprint Performance in Youth Soccer: A Comparison of FIFA 11+ and RAMP Protocols

This randomized clinical trial investigates the comparative effects of the FIFA 11+ and RAMP (Raise, Activate, Mobilize, Potentiate) warm-up protocols on the agility and sprint performance of young soccer players. The study involves 34 male players aged 8 to 15, who will be randomly assigned to one of the two …

8 - 15 years of age Male Phase N/A

A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors

A phase Ⅰ clinical study evaluating the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of GEN-725 tablets in patients with advanced solid tumors.

18 - 75 years of age All Phase 1
R Ruoyu Wang

A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

To evaluate the safety, tolerability of SIBP-A10 and determine the maximum tolerable dose (MTD) and phase II recommended dose (RP2D).

18 - 75 years of age All Phase 1
Y Yan Epelboym, MD, MPH

Efficacy of Routine Saline Flushing in the Prevention of Nephrostomy Tube Obstructions: A Pilot Study

The investigators performing this research to study if routine flushing is necessary to prevent obstructions of a nephrostomy tube. This study will evaluate patients that have nephrostomy tube or will have nephrostomy tubes placed as part of their standard clinical care. If participants agree to participate in this study, participants …

18 - 80 years of age All Phase N/A
V Valentina Azzollini, MD

Evaluation of a Multimodal Tactile Feedback System for Upper Limb-loss Users: Embodiment and Performance

The aim of this study is to evaluate the effect of integrating tactile feedback systems into a robotic upper-limb prosthesis. These systems deliver pressure stimuli (through small silicone chambers that inflate), vibration stimuli (through small circular actuators), or a combination of both to the arm, in order to improve the …

18 - 80 years of age All Phase N/A
X Xu Zhang

A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

This study aims to compare the efficacy and safety of rezvilutamide with enzalutamide in the treatment of patients with low-volume metastatic hormone sensitive prostate cancer.

18 years of age Male Phase 3

A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal Tuberculosis

This study adopts a combined design of retrospective cohort study followed by prospective observational study, which is conducted at Beijing Chest Hospital. The study first collects and analyzes the data of intestinal tuberculosis patients diagnosed and followed up in the hospital from 2011-1 to 2025-12 (a 15-year retrospective period) as …

18 - 100 years of age All Phase N/A

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

This clinical trial is an open-label, single-arm, non-randomized, dose-escalation and dose-expansion study targeting subjects with unresectable, advanced, malignant solid tumors who have failed or are unsuitable for standard treatments or refused the existing treatments. This study is divided into a dose-escalation phase (Phase I) and a dose-expansion phase (Phase II). …

18 years of age All Phase 1/2
N Nucleus Network, Melbourne

A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.

21 - 60 years of age All Phase 1

Simplify language using AI